The strongest outcomes are consistently observed in individuals who pair injections with sustainable lifestyle habits
Shipping and Handling ($15$35/shipment): Cold-chain shipping for injectable medications requires insulated packaging and ice packs
Mountjoy M, Sundgot-Borgen J, Burke L, et al
Eli Lilly reported its first Phase 3 readout (TRIUMPH-4) in December 2025, showing about 28.7% weight loss at 68 weeks, and a larger pivotal trial (TRIUMPH-1) in May 2026 showing about 28.3% weight loss at 80 weeks in 2,339 participants
In certain cases, healthcare providers may recommend microdosing GLP-1 drugs as part of a personalized treatment plan, particularly for patients with underlying gastrointestinal issues
The GEP12 doseresponse (0.1100 nM) binding assay was performed in a duplicate